EANM guideline on quality risk management for radiopharmaceuticals

Author
Patt, Marianne
Ocak, Meltem
Todde, Sergio
Ferrari, Valentina
Walte, Almut
Gillings, Nic
Hjelstuen, Olaug
Behe, Martin
Decristoforo, Clemens
Elsinga, Philip H.
Kiss, Oliver C.
Kolenc, Petra
Koziorowski, Jacek
Laverman, Peter
Mindt, Thomas L.
Metadata
Show full item record
Abstract
This document is intended as a supplement to the EANM "Guidelines on current Good Radiopharmacy Practice (cGRPP)" issued by the Radiopharmacy Committee of the EANM (Gillings et al. in EJNMMI Radiopharm Chem. 6:8, 2021). The aim of the EANM Radiopharmacy Committee is to provide a document that describes how to manage risks associated with small-scale "in-house" preparation of radiopharmaceuticals, not intended for commercial purposes or distribution.
URI
http://hdl.handle.net/20.500.12627/182423
https://avesis.istanbul.edu.tr/api/publication/3e54c7b4-b4c2-418f-9112-2f9e5bd6edc5/file
https://doi.org/10.1007/s00259-022-05738-4
Collections